CJC-1295
PreclinicalCJC-1295 with DAC · DAC:GRF
CJC-1295 is a modified GHRH analog with a Drug Affinity Complex (DAC) that binds to serum albumin, dramatically extending its half-life compared to native GHRH. It produces sustained elevation of GH and IGF-1 levels over days rather than hours. Research focuses on body composition improvements, muscle growth, and fat loss through prolonged GH axis stimulation.
C₁₅₂H₂₅₂N₄₂O₄₂S · 3647.28 Da
Available fromBC9Behemoth LabzPureRawz